NCT06628661View on ClinicalTrials.gov

Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 Cm and Microvascular Invasion

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Hepatocellular Carcinoma (HCC)Solitary Mass
Interventions
PROCEDURE

Surgery for HCC larger than 6.5 cm

Surgery for HCC larger than 6.5 cm without mVI

PROCEDURE

Surgery for HCC larger than 2 cm

Surgery for HCC larger than 2 cm with mVI

Trial Locations (1)

330

RECRUITING

Chang Gung Medical Foundation, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER